Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Soci

[
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Soci
[og_img]
https://www.investing.com/news/press-releases/applied-therapeutics-presents-full-12month-clinical-results-and-new-topline-data-from-inspire-phase-23-trial-of-govorestat-in-cmtsord-in-latebreaking-oral-presentation-at-the-peripheral-nerve-soci-93CH-4051645


Investing.com